These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7827170

  • 21. The influence of phosphorothioate oligodeoxynucleotides on various organs in vivo.
    Nieborowska-Skórska M, Białek AP, Nicolaides NC, Iozzo RV, Kawalec M, Calabretta B, Kawiak J, Marlicz K, Skórski T.
    Folia Histochem Cytobiol; 1996; 34(2):69-73. PubMed ID: 8875213
    [Abstract] [Full Text] [Related]

  • 22. Poor cellular uptake of antisense oligodeoxynucleotides: an obstacle to their use in chronic myeloid leukaemia.
    Clark RE.
    Leuk Lymphoma; 1995 Oct; 19(3-4):189-95. PubMed ID: 8535209
    [Abstract] [Full Text] [Related]

  • 23. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.
    J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233
    [Abstract] [Full Text] [Related]

  • 24. Antisense oligodeoxynucleotides against the BZLF1 transcript inhibit induction of productive Epstein-Barr virus replication.
    Diabata M, Enzinger EM, Monroe JE, Kilkuskie RE, Field AK, Mulder C.
    Antiviral Res; 1996 Mar 03; 29(2-3):243-60. PubMed ID: 8739603
    [Abstract] [Full Text] [Related]

  • 25. Antisense strategies to inhibit restenosis.
    Lee M, Simon AD, Stein CA, Rabbani LE.
    Antisense Nucleic Acid Drug Dev; 1999 Oct 03; 9(5):487-92. PubMed ID: 10555157
    [Abstract] [Full Text] [Related]

  • 26. Inhibition by modified oligodeoxynucleotides of the expression of type-1 plasminogen activator inhibitor in human endothelial cells.
    Cierniewski CS, Babinska A, Swiatkowska M, Wilczynska M, Okruszek A, Stec WJ.
    Eur J Biochem; 1995 Jan 15; 227(1-2):494-9. PubMed ID: 7851428
    [Abstract] [Full Text] [Related]

  • 27. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
    Smetsers TF, Skorski T, van de Locht LT, Wessels HM, Pennings AH, de Witte T, Calabretta B, Mensink EJ.
    Leukemia; 1994 Jan 15; 8(1):129-40. PubMed ID: 8289478
    [Abstract] [Full Text] [Related]

  • 28. Synthetic oligonucleotides: the development of antisense therapeutics.
    Monteith DK, Levin AA.
    Toxicol Pathol; 1999 Jan 15; 27(1):8-13. PubMed ID: 10367666
    [Abstract] [Full Text] [Related]

  • 29. Chimeric oligodeoxynucleotide analogues: enhanced cell uptake of structures which direct ribonuclease H with high specificity.
    Giles RV, Spiller DG, Tidd DM.
    Anticancer Drug Des; 1993 Feb 15; 8(1):33-51. PubMed ID: 8386514
    [Abstract] [Full Text] [Related]

  • 30. Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation.
    Takabe K, Lebrun JJ, Nagashima Y, Ichikawa Y, Mitsuhashi M, Momiyama N, Ishikawa T, Shimada H, Vale WW.
    Endocrinology; 1999 Jul 15; 140(7):3125-32. PubMed ID: 10385405
    [Abstract] [Full Text] [Related]

  • 31. Elimination of clonogenic Philadelphia-positive cells using BCR-ABL antisense oligodeoxynucleotides.
    de Fabritiis P, Amadori S, Calabretta B, Mandelli F.
    Bone Marrow Transplant; 1993 Sep 15; 12(3):261-5. PubMed ID: 8241986
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An antisense Bcr-Abl phosphodiester-tailed methylphosphonate oligonucleotide reduces the growth of chronic myeloid leukaemia patient cells by a non-antisense mechanism.
    Smetsers TF, Linders EH, van de Locht LT, de Witte TM, Mensink EJ.
    Br J Haematol; 1997 Feb 15; 96(2):377-81. PubMed ID: 9029029
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG, Joshi SS, Chan WC, Iversen PL, Jackson JD, Kessinger A, Pirruccello SJ, Sanger WG, Sharp JG, Verbik DJ.
    Leuk Lymphoma; 1995 Dec 15; 20(1-2):67-76. PubMed ID: 8750625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.